Retatrutide is a next-generation peptide-based drug designed for weight management and metabolic health. It works by mimicking natural hormones in the body that regulate appetite, blood sugar, and energy balance.

Specifically, Retatrutide is a triple agonist—meaning it activates three different hormone receptors at once:

• GLP-1 (glucagon-like peptide-1)

• GIP (glucose-dependent insulinotropic polypeptide)

• Glucagon receptors

By stimulating these pathways, Retatrutide helps:

• Reduce appetite and food intake

• Enhance insulin sensitivity

• Increase energy expenditure and fat burning

In simpler terms, Retatrutide sends powerful signals to the brain and body that promote weight loss and metabolic regulation, making it one of the most advanced and promising peptide-based treatments currently in development. It's being studied as a potential breakthrough for obesity, type 2 diabetes, and related conditions.